Company
Building the next generation of antiviral therapies
Our team
Senior Leadership
Greg Merril
CEO
35+ years leading life science ventures. Prior exits (NYSE, NASDQ)
Yong-Yuan Zhang MD, PhD
CSO, Founder
35+ years in infectious disease clinical development and virology research
Lisa Richardson MBA
CBO, CFO
25+ years in biotech and pharma, BD, strategy, finance